Rakhee Ganti
Founder and CEO,
Dimer Pharmaceuticals
United States
Dr. Rakhee Ganti is an accomplished scientist, entrepreneur, and innovator with a deep passion for transforming the treatment landscape for neurodegenerative diseases and cancer. During her doctoral studies at the Georgia Institute of Technology, she made a groundbreaking discovery of a novel mammalian disaggregase complex, which has been instrumental in shaping her approach to tackling diseases like Alzheimer’s.
Dr. Ganti brings a wealth of experience across regulatory affairs, medical writing, and discovery biology, having held impactful roles in leading biopharmaceutical companies. Her contributions include designing successful regulatory strategies, advancing adaptive clinical trials, and uncovering novel therapeutic targets, all aimed at addressing unmet medical needs.
Fueled by her innovative “Oncodegenic Approach,” Dr. Ganti founded Dimer Pharmaceuticals to explore the biological intersection of cancer and neurodegeneration. Her visionary leadership, coupled with her ability to translate cutting-edge science into actionable therapies, positions Dimer as a leader in the biotech space, dedicated to delivering life-changing treatments and redefining possibilities for patients worldwide.
Suffix
PhD
Sessions
-
10-Feb-2025Dimer Pharmaceuticals
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}